Immunoassay Market Size, Share & Trends Analysis Report By Product (Reagent & Kits, Analyzers/Instruments), By Technology (RIA, ELISA), By Application, By Specimen, By End-use, By Region, And Segment Forecasts, 2024 - 2030
- Report ID: GVR-3-68038-066-8
- Number of Pages: 180
- Format: Electronic (PDF)
- Historical Range: 2018 - 2022
- Industry: Healthcare
Market Segmentation
- Immunoassay Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Immunoassay Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Immunoassay Application Outlook (Revenue, USD Million, 2018 - 2030)
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Immunoassay End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Immunoassay Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- North America Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- North America Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- North America Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- North America Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- North America Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- U.S.
- U.S. Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- U.S. Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- U.S. Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- U.S. Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- U.S. Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- U.S. Immunoassay Market, By Product
- Canada
- Canada Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Canada Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Canada Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Canada Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Canada Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Canada Immunoassay Market, By Product
- North America Immunoassay Market, By Product
- Europe
- Europe Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Europe Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Europe Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Europe Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Europe Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- U.K.
- U.K. Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- U.K. Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- U.K. Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- U.K. Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- U.K. Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- U.K. Immunoassay Market, By Product
- Germany
- Germany Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Germany Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Germany Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Germany Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Germany Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Germany Immunoassay Market, By Product
- France
- France Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- France Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- France Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- France Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- France Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- France Immunoassay Market, By Product
- Italy
- Italy Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Italy Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Italy Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Italy Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Italy Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Italy Immunoassay Market, By Product
- Spain
- Spain Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Spain Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Spain Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Spain Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Spain Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Spain Immunoassay Market, By Product
- Denmark
- Denmark Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Denmark Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Denmark Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Denmark Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Denmark Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Denmark Immunoassay Market, By Product
- Sweden
- Sweden Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Sweden Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Sweden Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Sweden Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Sweden Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Sweden Immunoassay Market, By Product
- Norway
- Norway Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Norway Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Norway Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Norway Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Norway Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Norway Immunoassay Market, By Product
- Europe Immunoassay Market, By Product
- Asia Pacific
- Asia Pacific Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Asia Pacific Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Asia Pacific Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Asia Pacific Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Asia Pacific Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Japan
- Japan Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Japan Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Japan Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Japan Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Japan Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Japan Immunoassay Market, By Product
- China
- China Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- China Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- China Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- China Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- China Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- China Immunoassay Market, By Product
- India
- India Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- India Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- India Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- India Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- India Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- India Immunoassay Market, By Product
- South Korea
- South Korea Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- South Korea Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- South Korea Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- South Korea Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- South Korea Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- South Korea Immunoassay Market, By Product
- Australia
- Australia Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Australia Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Australia Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Australia Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Australia Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Australia Immunoassay Market, By Product
- Thailand
- Thailand Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Thailand Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Thailand Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Thailand Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Thailand Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Thailand Immunoassay Market, By Product
- Asia Pacific Immunoassay Market, By Product
- Latin America
- Latin America Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Latin America Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Latin America Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Latin America Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Latin America Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Brazil
- Brazil Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Brazil Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Brazil Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Brazil Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Brazil Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Brazil Immunoassay Market, By Product
- Mexico
- Mexico Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Mexico Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Mexico Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Mexico Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Mexico Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Mexico Immunoassay Market, By Product
- Argentina
- Argentina Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Argentina Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Argentina Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Argentina Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Argentina Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Argentina Immunoassay Market, By Product
- Latin America Immunoassay Market, By Product
- Middle East & Africa
- Middle East & Africa Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Middle East & Africa Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Middle East & Africa Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Middle East & Africa Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Middle East & Africa Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- South Africa
- South Africa Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- South Africa Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- South Africa Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- South Africa Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- South Africa Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- South Africa Immunoassay Market, By Product
- Saudi Arabia
- Saudi Arabia Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- Saudi Arabia Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- Saudi Arabia Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- Saudi Arabia Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- Saudi Arabia Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- Saudi Arabia Immunoassay Market, By Product
- UAE
- UAE Immunoassay Market, By Product
- Reagents & Kits
- ELISA Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
- Analyzers/Instruments
- Open Ended Systems
- Closed Ended Systems
- Software & Services
- Reagents & Kits
- UAE Immunoassay Market, By Technology
- Radioimmunoassay (RIA)
- Enzyme Immunoassays (EIA)
- Chemiluminescence Immunoassays (CLIA)
- Fluorescence Immunoassays (FIA)
- Rapid Test
- Others
- UAE Immunoassay Market, By Application
- Therapeutic Drug Monitoring
- Oncology
- Cardiology
- Endocrinology
- Infectious Disease Testing
- Autoimmune Diseases
- Others
- UAE Immunoassay Market, By End-use
- Hospitals
- Blood Banks
- Clinical Laboratories
- Pharmaceutical and Biotech Companies
- Academic Research Centers
- Others
- UAE Immunoassay Specimen Outlook (Revenue, USD Million, 2018 - 2030)
- Blood
- Saliva
- Urine
- Other Specimens
- UAE Immunoassay Market, By Product
- Middle East & Africa Immunoassay Market, By Product
- North America
Immunoassay Market Dynamics
Driver: Growing incidence of infectious and chronic diseases
The increasing incidence of chronic diseases, including diabetes, cardiovascular diseases, cancer, & gastrointestinal diseases, is a major factor driving this market globally. According to the IARC, over 20.77 million new cancer cases are projected to be diagnosed in 2023. Immunoassay techniques are significant for the determination of oncogenesis & diagnosis of cancer and identification of its different stages. Immunoassay technology also facilitates the use of monoclonal & polyclonal antibodies for the detection of specific antigenic molecules in tissues and aids in rapid identification of tumor antigens. Hence, an increase in the number of diagnosed cancer cases is anticipated to drive the growth of the immunoassay market. As per WHO (2020), over 71 million people worldwide are suffering from chronic hepatitis C infection. Immunoassays can provide a promising solution for high-throughput and reliable diagnosis of such infectious diseases.
Driver: Rising demand for POC diagnostics
Growing concerns regarding infections caused by multidrug-resistant bacteria and frequent disease outbreaks in endemic areas are generating the need for point-of-care technologies to enable testing of large population subsets. Moreover, genetic variation in hosts & pathogens, population pressure, and environmental changes are fueling a rapid increase in the incidence of emerging diseases. As a result, point-of-care applications of immunoassays are gaining a strong foothold within the diagnostics space. In addition, regulatory bodies such as WHO, CDC, and ECDC are actively recording incidence & prevalence, and working with local governments to achieve overall control of treatment & management of infectious diseases. For instance, the Global Influenza Programme (GIP), by WHO, provides technical support, strategic guidance, and coordination activities concerning zoonotic diseases, pandemics, & seasonal influenzas. Similarly, the CDC continuously strives to control epidemics in India, as it is a high-risk country. With an initial focus on preventing HIV/AIDS, the CDC has now expanded its scope to address additional diseases in India, including influenza & tuberculosis, immunization, and antimicrobial resistance. Such initiatives facilitate the strengthening of surveillance activities, which require point-of-care immunoassays for large-scale and efficient diagnostic testing.
Restraint: Limitations of immunoassay techniques
Accurate diagnosis of cancerous growth is important in facilitating effective disease diagnosis. There is a lack of specificity with immunoassay techniques. Some types of tumors do not have tumor-specific antibodies that can be accepted, for example, malignant mesothelioma. Thus, supportive confirmatory tests are required, which add to the financial burden of patients. To minimize and avoid false-positive results, the specificity of antibodies needs to be examined. Thus, the lack of specificity associated with immunoassay techniques and a need for multimodal approaches for disease diagnosis are anticipated to impede market growth. Higher costs associated with immunoassays are another factor hindering market growth.
What Does This Report Include?
This section will provide insights into the contents included in this immunoassay market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Immunoassay market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Immunoassay market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
